FDA Wants 14 Drugmakers to Stop Misleading Ads

By Anna Boyd
22:48, April 5th 2009
34 votes
Vote this story

The Internet is full of promotional ads of drugs and I am sure you thought at least once in your life of buying one because you considered it is safe for you.
 
The Food and Drug Administration however considers these ads a threat to the population as they do not present side effects as well. That’s why, the agency has sent warning letters to the world’s 14 leading drug companies asking them to pull out what the agency called “misleading” ads on Internet search engines.
 
“For promotional materials to be truthful and non-misleading, they must contain risk information in each part as necessary to qualify any claims made about the drug,” the FDA wrote in one of its letters.
 
The ads are usually found on search engine operators such as Google and Yahoo, which post links to their Web sites in a sidebar and in turn get paid by the drugmakers and interest groups.
 
The companies receiving a warning letter from the FDA were: Bayer, Biogen Idec, Boehringer Ingelheim, Eli Lilly, Forest Laboratories, Genentech, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche and Sanofi-Aventis. Forty-eight drugs were involved in the FDA action, 19 of which carry the FDA’s strongest warning, a black box, about possible side effects.
 
These companies are expected to give an answer to the FDA by the end of next week.



© 2007 - 2009 - eFluxMedia
dotclear

Other News in

dotclear
Latest videos in Specials
And Finally Hair Do nots
Rocky Mountain News Closing...
Love is in the air balloon
T.I. Says No to Parties and...
Which Jonas Brother Will...

dotclear
Specials You are here: Specials
» Blogs   » Specials   
E-mail To A Friend Print RSS Text size: Decrease font size Increase font size
dotclear
dotclear
dotclear

Interested In This Topic?

News Alert will keep you informed. Find out more.
dotclear
Photos Gallery
dotclear